Analyzing the color of red blood cells could help predict survival outcomes among people with systemic sclerosis (SSc), a…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
People with systemic sclerosis (SSc) who have more severe digestive problems tend to have less diversity in the makeup…
Epigenetic changes in immune cells from African American women with systemic sclerosis (SSc) may differ from those in patients…
A new study shows that UVA1 phototherapy — a treatment strategy that uses specific wavelengths of ultraviolet light — may…
The case of a person with scleroderma who successfully received a lung transplant from a donor who had tested…
Analyzing the global genetic activity of immune cells called monocytes can identify distinct groups among people with systemic scleroderma,…
People with systemic sclerosis (SSc) show higher levels of certain antibodies against the Epstein-Barr virus, which is suggestive of…
The first two groups of patients have been enrolled in a Phase 2a clinical trial that’s testing the cannabidiol-derived medication…
The U.S. Food and Drug Administration (FDA) has granted the experimental therapy efzofitimod fast track status as a potential treatment…
Levels of a type of immune cell called T-cells are elevated in skin biopsies from children with localized scleroderma,…